Screening-based approaches to identify small molecules that inhibit protein–protein interactions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Screening-based approaches to identify small molecules that inhibit protein–protein interactions

Published:2017-01-20 Issue:3 Volume:12 Page:293-303
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Choi Sehee¹²,Choi Kang-Yell¹²³

Affiliation:

1. Translational Research Center for Protein Function Control, Yonsei University, Seoul, Korea

2. Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Korea

3. CK Biotechnology Inc., 416 Advanced Science and Technology Center, 50 Yonsei-ro, Seoul, Korea

Funder

National Research Foundation of Korea

Publisher

Informa UK Limited

Subject

Drug Discovery

Link

https://www.tandfonline.com/doi/pdf/10.1080/17460441.2017.1280456

Reference103 articles.

1. STRING v10: protein–protein interaction networks, integrated over the tree of life

2. Network medicine: a network-based approach to human disease

3. Structure-PPi: a module for the annotation of cancer-related single-nucleotide variants at protein–protein interfaces: Fig. 1.

4. Three-dimensional reconstruction of protein networks provides insight into human genetic disease

5. Protein–protein interaction inhibitors get into the groove

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Repositioning Using Computer-aided Drug Design (CADD);Current Pharmaceutical Biotechnology;2024-02

2. Enhanced Thermal Stability and Reduced Aggregation in an Antibody Fab Fragment at Elevated Concentrations;Molecular Pharmaceutics;2023-04-11

3. Identifying promising druggable binding sites and their flexibility to target the receptor-binding domain of SARS-CoV-2 spike protein;Computational and Structural Biotechnology Journal;2023

4. Small-Molecule Inhibitors of Protein–Protein Interactions as Therapeutics;Protein-Protein Interactions;2023

5. Medicinal Chemistry Strategies for the Development of Inhibitors Disrupting β-Catenin’s Interactions with Its Nuclear Partners;Journal of Medicinal Chemistry;2022-12-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3